Determine susceptibility testing of Candida spp. directly from colonies grown on non-selective media using InMicro® Prepared: RPMI 1640 Agar with MOPS and 2% Glucose.
$292.00
Determine susceptibility to antifungal agents by testing Candida spp. directly from colonies grown on non-selective media with InMicro® Prepared: RPMI 1640 Agar with MOPS and 2% Glucose. RPMI 1640 was developed by Moore et al. and is based on RPMI-1630 series of media utilizing a bicarbonate buffering system. When supplemented with morpholinepropanesulfonic acid (MOPS), glucose and agar, RPMI-1640 has demonstrated accuracy for use with gradient-based systems with results comparable to that obtained for testing Candida spp. against antifungal agents.
Invasive fungal infections are of great clinical relevance and pose therapeutic challenges due to increasing resistance to the most commonly prescribed antifungals. Concerns of emerging resistance and the introduction of new antifungal agents have led to increased demand for accurate species identification and antifungal susceptibility testing.
RPMI 1640 Agar with MOPS and 2% glucose is a plated medium that is used with antibiotic gradient-based systems for susceptibility testing of Candida spp. which causes nonsocomical bloodstream infections (BSI) in the United States.
RPMI-1640 medium is widely used in cell culture and also as a reference method for antifungal broth microdilution. The use of RPMI-1640 medium supplemented with MOPS, agar, and glucose in the yeast susceptibility test in conjunction with antifungal gradient-based systems has been widely published and suggested as a reliable alternative to traditional broth dilution since the 1990s.
RPMI 1640 Agar with MOPS and 2% Glucose contains MOPs, glucose, RPMI-1640, agar and demineralized water. This medium uses gradient-based systems. The gradient method is based on a combination of the concepts of both dilution and diffusion tests, but differs from conventional disk methods. When the strip is applied to the inoculated agar plate , there is an immediate release of the antibiotic into the agar matrix. A continuous and exponential gradient of antibiotic concentration is created beneath the carrier.
Manufactured at a cGMP-compliant facility under the ISO 13485 standard, ensuring high-quality manufacturing standards, consistency, and reliability for both research and industrial settings.
Agar
Plated
Product Quantity | Pack of 10 |
---|